Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Jinze Li, Yunxiang Li, Dehong Cao, Yin Huang, Lei Peng, Chunyang Meng & Qiang Wei. (2022) The association between histological prostatitis and benign prostatic hyperplasia: a single-center retrospective study. The Aging Male 25:1, pages 95-100.
Read now
Read now
Ming Li, Da-Ming Xu, Shu-Bin Lin, Zheng-Liang Yang, Teng-Yu Xu, Jin-Huan Yang, Ze-Xin Lin, Ze-Kai Huang & Jun Yin. (2021) Investigation of Lymphocyte Subsets in Peripheral Blood of Patients with Benign Prostatic Hyperplasia. International Journal of General Medicine 14, pages 6951-6959.
Read now
Read now
Yi-Hao Peng, Chien-Wen Huang, Che-Yi Chou, Hung-Jie Chiou, Hsuan-Ju Chen, Trong-Neng Wu & Wen-Chao Ho. (2020) Association between asthma and risk of benign prostatic hyperplasia: a retrospective population-based study . The Aging Male 23:5, pages 599-606.
Read now
Read now
Subo Qian, Xujun Sheng, Ding Xu, Haibo Shen, Jun Qi & Yu Wu. (2020) Variation of prostatic morphology in Chinese benign prostatic hyperplasia patients of different age decades. The Aging Male 23:5, pages 457-463.
Read now
Read now
Hung-Jen Shih, Pei-Shan Tsai, Yu-Ching Wen, Ming-Chang Kao, Yen-Chun Fan & Chun-Jen Huang. (2020) Hyperlipidemia patients with long-term statin treatment are associated with a reduced risk of progression of benign prostatic enlargement. The Aging Male 23:5, pages 354-361.
Read now
Read now
Peng Zhang & Xing-Huan Wang. (2020) Comment on the paper entitled “high serum concentration of estradiol may be a risk factor of prostate enlargement in aging male in China”. The Aging Male 23:2, pages 169-170.
Read now
Read now
Adachukwu Pauline Ikeyi, Innocent Uzochukwu Okagu, Lawrence Uchenna Sunday Ezeanyika & Edwin Olisah Alumanah. (2020) Zapoteca portoricensis root crude methanol extract and its fractions normalizes aberrations associated with benign prostatic hyperplasia in rats. All Life 13:1, pages 360-372.
Read now
Read now
Aldo E. Calogero, Giovanni Burgio, Rosita A. Condorelli, Rossella Cannarella & Sandro La Vignera. (2019) Epidemiology and risk factors of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. The Aging Male 22:1, pages 12-19.
Read now
Read now
Roderick MacDonald, Michelle Brasure, Philipp Dahm, Carin M. Olson, Victoria A. Nelson, Howard A. Fink, Michael C. Risk, Bruce Rwabasonga & Timothy J. Wilt. (2019) Efficacy of newer medications for lower urinary tract symptoms attributed to benign prostatic hyperplasia: a systematic review. The Aging Male 22:1, pages 1-11.
Read now
Read now
Aldo E. Calogero, Giovanni Burgio, Rosita A. Condorelli, Rossella Cannarella & Sandro La Vignera. (2018) Treatment of lower urinary tract symptoms/benign prostatic hyperplasia and erectile dysfunction. The Aging Male 21:4, pages 272-280.
Read now
Read now
Muhammet Guzelsoy, Mustafa Murat Aydos, Soner Coban, Ali Riza Turkoglu, Kadir Acibucu & Hakan Demirci. (2018) Comparison of the effectiveness of IPSS and VPSS without any help in LUTS patients: a prospective study. The Aging Male 21:3, pages 193-199.
Read now
Read now
Carlos King-ho Wong, Edmond Pui-Hang Choi, Steve Wai-Hee Chan, James Hok-leung Tsu, Chi-wai Fan, Peggy Sau-kwan Chu, Fu-keung Cheung, Wai-Kit Ma, Ida Soo Fan Mah, Sidney Kam-hung Yip, Simon See-ming Hou, Hing-Shing So & CindyLo-kuen Lam. (2017) Use of the International Prostate Symptom Score (IPSS) in Chinese male patients with benign prostatic hyperplasia. The Aging Male 20:4, pages 241-249.
Read now
Read now
Xiaoqiang Qian, Ding Xu, Hailong Liu, Xiaoling Lin, Yongjiang Yu, Jian Kang, Xujun Sheng, Jianfeng Xu, Siqun Zheng, Danfeng Xu & Jun Qi. (2017) Genetic variants in 5p13.2 and 7q21.1 are associated with treatment for benign prostatic hyperplasia with the α-adrenergic receptor antagonist. The Aging Male 20:4, pages 250-256.
Read now
Read now
Xiaoqiang Qian, Hailong Liu, Ding Xu, Le Xu, Fang Huang, Wei He, Jun Qi, Yu Zhu & Danfeng Xu. (2017) Functional outcomes and complications following B-TURP versus HoLEP for the treatment of benign prostatic hyperplasia: a review of the literature and Meta-analysis. The Aging Male 20:3, pages 184-191.
Read now
Read now
Articles from other publishers (21)
Ziqiang Wang, Qian Mao, Yong Yuan, Chuan Wang & Hao Wei. (2023) Shuangshi Tonglin Capsule treats benign prostatic hyperplasia through the ROS/NLRP3 signaling pathway. International Urology and Nephrology.
Crossref
Crossref
Guo-Yu Gong, Sheng-Yan Xi, Cheng-Chen Li, Wen-Li Tang, Xue-Ming Fu & Yuan-Peng Huang. (2023) Bushen Tongluo formula ameliorated testosterone propionate-induced benign prostatic hyperplasia in rats. Phytomedicine 120, pages 155048.
Crossref
Crossref
Ansh Bhatia, Joao Gabriel Porto, Aneesha Maini, Deepak Langade, Thomas R. W. Herrmann, Hemendra Navinchandra Shah & Shivank Bhatia. (2023) One‐year outcomes after prostate artery embolization versus laser enucleation: A network meta‐analysis. BJUI Compass.
Crossref
Crossref
Tingting Yang, Jiayu Yuan, Yuting Peng, Jiale Pang, Zhen Qiu, Shangxiu Chen, Yuhan Huang, Zhenzhou Jiang, Yilin Fan, Junjie Liu, Tao Wang, Xueyan Zhou, Sitong Qian, Jinfang Song, Yi Xu, Qian Lu & Xiaoxing Yin. (2023) Metformin: A promising clinical therapeutical approach for BPH treatment via inhibiting dysregulated steroid hormones-induced prostatic epithelial cells proliferation. Journal of Pharmaceutical Analysis.
Crossref
Crossref
Ying Cao, Heng Zhang, Xiao-Hu Tang, Gui-Lan Tu, Ye Tian, Guang-Heng Luo, Yan-Dong Wang, Zhen Wang, Lin-yue An, Mu-Xia Luo & Lei Tang. (2023) Alterations in the balance of sex hormones may affect rat prostatic inflammation and fibrosis, and osteopontin might be involved in this process. International Urology and Nephrology 55:9, pages 2355-2365.
Crossref
Crossref
Maxim Masiutin & Maneesh Yadav. (2023) Alternative androgen pathways. WikiJournal of Medicine 10:1, pages 3.
Crossref
Crossref
Fatemeh Azadeh, Fatemeh Zahra Gharib & Seyed Mohammad Hosseini. (2022) Effects of Glycyrrhiza Glabra (Licorice) Root Extract on the Hormones, Serum Biochemicals, and Hematological Parameters in Dogs with Benign Prostatic Hyperplasia. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-9.
Crossref
Crossref
Bo Wang, Di Pan, Yong Ban, Zhaolin Sun, Ye Tian & Guangheng Luo. (2022) The relationship between prostatic microvessel density and different concentrations of oestrogen/androgen in Sprague-Dawley rats. European Journal of Medical Research 27:1.
Crossref
Crossref
Zheng Ma, Zhenfan Wang, Chen Xu & Minjun Jiang. (2022) Shikonin alleviates testosterone-induced benign prostatic hyperplasia in rats via the Nrf2-ARE and NF-κB pathway. Molecular & Cellular Toxicology.
Crossref
Crossref
Xiaoma Zhang, Li Xiao, Li Zhang, Jun Zhou, Zongyao Hao, Cheng Yang & Chaozhao Liang. (2022) Associated Factors for Prostate Enlargement in Chinese Adult Men Aged <40 Receiving Checkups. International Journal of Clinical Practice 2022, pages 1-7.
Crossref
Crossref
Diana Elizabeth Alcantara-Zapata, Aníbal J Llanos & Carolina Nazzal. (2022) High altitude exposure affects male reproductive parameters: could it also affect the prostate?. Biology of Reproduction 106:3, pages 385-396.
Crossref
Crossref
Ying Cao, Ye Tian, Heng Zhang, Guang-Heng Luo, Zhao-Lin Sun & Shu-Jie Xia. (2022) Imbalance in the estrogen/androgen ratio may affect prostate fibrosis through the TGF-β/Smad signaling pathway. International Urology and Nephrology 54:3, pages 499-508.
Crossref
Crossref
ZhiWei Liu, Ting Chen, Mingkang Shen, Kai Li, ChunJie Ma, Antonnette Ketlhoafetse & XiangYun Liu. (2020) A Pilot Study on the Effects of Yi Jin Jing Exercise for Older Men with Benign Prostatic Hyperplasia. Journal of Aging and Physical Activity 28:6, pages 822-827.
Crossref
Crossref
Ximena Guzman Robledo & Herney Andrés García-Perdomo. (2020) Mecanismos inflamatorios involucrados en la fisiopatología de la hiperplasia prostática benigna. Revista Urología Colombiana / Colombian Urology Journal 29:04, pages 240-244.
Crossref
Crossref
Xi Jin, Tianhai Lin, Guang Yang, Huawei Cai, Bo Tang, Xinyang Liao, Huifang Li, Xiaoting Chen, Lina Gong, Hang Xu, Yi Sun, Ping Tan, Jianqiong Yin, Hongwen Ma, Jianzhong Ai, Kunjie Wang, Qiang Wei, Lu Yang & Hong Li. (2020) Use of Tregs as a cell‐based therapy via CD39 for benign prostate hyperplasia with inflammation. Journal of Cellular and Molecular Medicine 24:9, pages 5082-5096.
Crossref
Crossref
Geovanni Espinosa & Ralph Esposito. 2020. Textbook of Natural Medicine. Textbook of Natural Medicine
1189
1195.e3
.
Lin Miao, Chanyuan Jiao, Rui Shao, Yaxin Qi, Guanwei Fan, Xiaojiang Li, Yuefei Wang, Yan Zhu, Ju Zhang & Xiumei Gao. (2019) Bakuchiol suppresses oestrogen/testosterone-induced Benign Prostatic Hyperplasia development through up-regulation of epithelial estrogen receptor β and down-regulation of stromal aromatase. Toxicology and Applied Pharmacology 381, pages 114637.
Crossref
Crossref
Weiyu Zhang, Xiaopeng Zhang, Haibin Li, Feng Wu, Huanrui Wang, Meishan Zhao, Hao Hu & Kexin Xu. (2019) Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study. BMJ Open 9:6, pages e022792.
Crossref
Crossref
Rui Tao, Lin Miao, Xiean Yu, John Owoicho Orgah, Oche Barnabas, Yanxu Chang, Erwei Liu, Guanwei Fan & Xiumei Gao. (2019) Cynomorium songaricum Rupr demonstrates phytoestrogenic or phytoandrogenic like activities that attenuates benign prostatic hyperplasia via regulating steroid 5-α-reductase. Journal of Ethnopharmacology 235, pages 65-74.
Crossref
Crossref
Wei-Hsiang Chang, Yuh-Shyan Tsai, Jia-Yu Wang, Hsiu-Ling Chen, Wen-Horng Yang & Ching-Chang Lee. (2019) Sex hormones and oxidative stress mediated phthalate-induced effects in prostatic enlargement. Environment International 126, pages 184-192.
Crossref
Crossref
Gustavo Ferreira Simoes, Paula Sakuramoto, Caroline Brito dos Santos, Nilva Karla Cervigne Furlan & Taize Machado Augusto. 2018. Pathophysiology - Altered Physiological States. Pathophysiology - Altered Physiological States.